Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease

Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease

Dettagli Bibliografici
Autori principali:	Petousi, N, Pavord, ID, Kent, BD
Natura:	Journal article
Lingua:	English
Pubblicazione:	BMJ Publishing Group 2024

Documenti analoghi

Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report
di: McDonald, VM, et al.
Pubblicazione: (2019)

A new approach to the classification and management of airways diseases: identification of treatable traits
di: Shrimanker, R, et al.
Pubblicazione: (2017)

Change is in the air: key questions on the ‘Treatable Traits’ model for chronic airway diseases in primary care
di: Alvar Agusti, et al.
Pubblicazione: (2024-07-01)

Influence of sex, cigarette smoking and airway inflammation on treatable traits in CBIOPRED severe asthma
di: Cong Dong, et al.
Pubblicazione: (2022-09-01)

From treatable traits to GETomics in airway disease: moving towards clinical practice
di: Alberto Papi, et al.
Pubblicazione: (2024-01-01)

Patient activation is a treatable trait in patients with chronic airway diseases: An observational study
di: Jeannette B. Peters, et al.
Pubblicazione: (2022-10-01)

Treatable traits in an English cohort: prevalence and predictors of future decline in lung function and quality of life in COPD
di: Muhammad Rehan Sarwar, et al.
Pubblicazione: (2021-05-01)

Occluding mucous airway plugs in patients with obstructive lung diseases: a new treatable trait?
di: Alvar Agustí, et al.
Pubblicazione: (2025-01-01)

Measuring lung function in airways diseases: current and emerging techniques
di: Petousi, N, et al.
Pubblicazione: (2019)

Application of modern molecular microbiological techniques to identify treatable chronic bacterial airway infection in severe asthma
di: Jabeen, M, et al.
Pubblicazione: (2018)

Walking the path of treatable traits in interstitial lung diseases
di: Francesco Amati, et al.
Pubblicazione: (2023-10-01)

Non-typeable Haemophilus influenzae airways infection: the next treatable trait in asthma?
di: Hinks, TSC, et al.
Pubblicazione: (2022)

Non-typeable Haemophilus influenzae airways infection: the next treatable trait in asthma?
di: Mary Ashley Brown, et al.
Pubblicazione: (2022-09-01)

Lung Hyperinflation as Treatable Trait in Chronic Obstructive Pulmonary Disease: A Narrative Review
di: Koopman M, et al.
Pubblicazione: (2024-07-01)

Identification of pulmonary treatable traits in a real-life setting
di: Simpson, J, et al.
Pubblicazione: (2018)

A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future
di: Pérez de Llano L, et al.
Pubblicazione: (2020-09-01)

Treatable Traits in Chronic Respiratory Disease: A Comprehensive Review
di: Yong Qin Lee, et al.
Pubblicazione: (2021-11-01)

Asthma control, airway responsiveness and airway inflammation.
di: Pavord, I
Pubblicazione: (2009)

Associations between blood eosinophils and decline in lung function among adults with and without asthma
di: Hancox, RJ, et al.
Pubblicazione: (2018)

Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
di: Bafadhel M, et al.
Pubblicazione: (2015-06-01)

Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma.
di: Newby, C, et al.
Pubblicazione: (2014)

Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma
di: Newby, C, et al.
Pubblicazione: (2014)

Chronic tonsillar enlargement and cough: preliminary evidence of a novel and treatable cause of chronic cough.
di: Birring, S, et al.
Pubblicazione: (2004)

Biomarkers in severe asthma: Identifying the treatable trait
di: Aanchal Gvalani, et al.
Pubblicazione: (2023-01-01)

The Lancet COPD Commission: broader questions remain
di: Petousi, N, et al.
Pubblicazione: (2023)

Chronic rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma
di: José Antonio Castillo, MD, PhD, et al.
Pubblicazione: (2023-11-01)

Non-invasive assessment of airway inflammation
di: Pavord, I, et al.
Pubblicazione: (2009)

Sub-stratification of type-2 high airway disease for therapeutic decision-making: a ‘bomb' (blood eosinophils) meets ‘magnet' (FeNO) framework
di: Couillard, S, et al.
Pubblicazione: (2022)

The treatable traits of asthma in pregnancy: a clinical audit
di: Katarzyna Duszyk, et al.
Pubblicazione: (2024-06-01)

Treatable Traits in COPD – A Proposed Approach
di: Cardoso J, et al.
Pubblicazione: (2021-11-01)

Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease
di: Wang H, et al.
Pubblicazione: (2016-09-01)

Sputum induction to assess airway inflammation: is it an inflammatory stimulus?
di: Pavord, I
Pubblicazione: (1998)

Characteristics and treatable traits of patients with chronic obstructive pulmonary disease (COPD) with and without paid employment
di: Peter A. Jacobsen, et al.
Pubblicazione: (2021-05-01)

Airway function and markers of airway inflammation in patients with treated hypothyroidism.
di: Birring, S, et al.
Pubblicazione: (2005)

Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis
di: Andrea Gramegna, et al.
Pubblicazione: (2023-12-01)

Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD?
di: Cazzola M, et al.
Pubblicazione: (2023-09-01)

Bringing the treatable traits approach to primary care asthma management
di: Paul E. Pfeffer, et al.
Pubblicazione: (2023-09-01)

Treatment of severe stable COPD: the multidimensional approach of treatable traits
di: Marlies van Dijk, et al.
Pubblicazione: (2020-09-01)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
di: Siva R, et al.
Pubblicazione: (2014-02-01)

Non-invasive assessment of airway inflammation in asthma: An overview
di: Shaw, D, et al.
Pubblicazione: (2006)